Medicine NewsIn research that could open new avenues of treatment for seasonal allergies, a team of Yale University scientists has discovered how a poorly understood component of the human immune system triggers – and sometimes worsens – allergic reactions. The research appears in the May 24 Advance Online Publication of Nature Immunology. [...]
Comments Off
UroToday.com – This updated review of tadalafil (Cialis), one of the three available phosphodiesterase type 5 (PDE5) inhibitors that revolutionized the treatment of erectile dysfunction (ED), analyzes its latest clinical studies. Tadalafil’s most unique and identifying characteristic is its long half-life of 17.5 hours, compared with 4 hours for sildenafil (Viagra) and vardenafil [...]
Comments Off
Certain individuals have long been regarded as particularly susceptible to developing behavioural and emotional problems when they experience negative environmental conditions, due to the fact that they carry so-called ‘vulnerability genes’.
Comments Off
Academic Press, a division of Elsevier, would like to announce the publication of a new title in psychology; Evidence-Based Addiction Treatment by Peter Miller, PhD. The growing emphasis on accountability and cost effectiveness in the field of addictions treatment is leading to major changes in standards of care. Inconsistent practices based solely [...]
Comments Off
Just as our world buzzes with distractions – from phone calls to e-mails to tweets – the neurons in our brain are bombarded with messages. Research has shown that when we pay attention, some of these neurons begin firing in unison, like a chorus rising above the noise. Now, a study in the May 29 [...]
Comments Off
When someone becomes dependent on drugs or alcohol, the brain’s pleasure center gets hijacked, disrupting the normal functioning of its reward circuitry. Researchers investigating this addiction “switch” have now implicated a naturally occurring protein, a dose of which allowed them to get rats hooked with no drugs at all. [...]
Comments Off
Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from the National Institute for Health and Clinical Excellence (NICE) in the UK, which recommends considering a range of newer therapy options, including ‘Januvia’ (sitagliptin).
Researchers at the University of California, San Francisco, and collaborators at Harvard Medical School have linked a specialized protein in human muscles to the process that clears glucose out of the bloodstream, shedding light on what goes wrong in type 2 diabetes on a cellular level.